Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have unveiled a groundbreaking…
Read More
FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape
Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have unveiled a paradigm-shifting…
Read More
Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape.
Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have fundamentally challenged the…
Read More
Brain Tumors Induce Widespread Disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape
A groundbreaking study led by researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of…
Read More
Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain Tumors
In a landmark study that could redefine the treatment landscape for terminal brain cancer, a collaborative team of Canadian scientists…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
Glioblastoma Research Reveals Skull Bone Erosion and Immune System Manipulation by Aggressive Brain Tumors
In a landmark study published on October 3 in the journal Nature Neuroscience, researchers from the Montefiore Einstein Comprehensive Cancer…
Read More
Transforming immune cells into cancer-seeking ‘bloodhounds’ to eliminate tumors
A groundbreaking study by Stanford Medicine researchers has unveiled a novel immunotherapy approach that could revolutionize the treatment of solid…
Read More
Glioblastoma Beyond the Brain: Study Reveals How Lethal Tumors Reshape the Skull and Hijack the Immune System to Fuel Aggression
The traditional understanding of glioblastoma—a devastating and primary form of brain cancer—has long characterized the disease as a localized phenomenon,…
Read MoreYOU MAY HAVE MISSED
